BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22037217)

  • 1. Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation.
    Bian Y; Hall B; Sun ZJ; Molinolo A; Chen W; Gutkind JS; Waes CV; Kulkarni AB
    Oncogene; 2012 Jul; 31(28):3322-32. PubMed ID: 22037217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.
    Sun ZJ; Zhang L; Hall B; Bian Y; Gutkind JS; Kulkarni AB
    Clin Cancer Res; 2012 Oct; 18(19):5304-13. PubMed ID: 22859719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.
    Bian Y; Terse A; Du J; Hall B; Molinolo A; Zhang P; Chen W; Flanders KC; Gutkind JS; Wakefield LM; Kulkarni AB
    Cancer Res; 2009 Jul; 69(14):5918-26. PubMed ID: 19584284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.
    Hall B; Nakashima H; Sun ZJ; Sato Y; Bian Y; Husain SR; Puri RK; Kulkarni AB
    J Transl Med; 2013 Feb; 11():45. PubMed ID: 23421960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN deficiency contributes to the development and progression of head and neck cancer.
    Squarize CH; Castilho RM; Abrahao AC; Molinolo A; Lingen MW; Gutkind JS
    Neoplasia; 2013 May; 15(5):461-71. PubMed ID: 23633918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
    Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
    J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma.
    Georgy SR; Cangkrama M; Srivastava S; Partridge D; Auden A; Dworkin S; McLean CA; Jane SM; Darido C
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26063791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.
    Cameron S; de Long LM; Hazar-Rethinam M; Topkas E; Endo-Munoz L; Cumming A; Gannon O; Guminski A; Saunders N
    Mol Cancer; 2012 Sep; 11():74. PubMed ID: 23021083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
    Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
    Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.
    Ma SR; Wang WM; Huang CF; Zhang WF; Sun ZJ
    Oncotarget; 2015 Apr; 6(11):8807-21. PubMed ID: 25871396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that
    Izumi H; Wang Z; Goto Y; Ando T; Wu X; Zhang X; Li H; Johnson DE; Grandis JR; Gutkind JS
    Mol Cancer Ther; 2020 Jul; 19(7):1562-1571. PubMed ID: 32430488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
    Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
    Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation.
    Lu SL; Reh D; Li AG; Woods J; Corless CL; Kulesz-Martin M; Wang XJ
    Cancer Res; 2004 Jul; 64(13):4405-10. PubMed ID: 15231647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium.
    Eritja N; Felip I; Dosil MA; Vigezzi L; Mirantes C; Yeramian A; Navaridas R; Santacana M; Llobet-Navas D; Yoshimura A; Nomura M; Encinas M; Matias-Guiu X; Dolcet X
    Cell Death Differ; 2017 Aug; 24(8):1443-1458. PubMed ID: 28524854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway.
    Zhang HY; Wang ZQ; Li YY; Wang F; Zeng QR; Gao Y; Xuan XY; Li SS
    Oncol Rep; 2014 Nov; 32(5):2134-42. PubMed ID: 25175594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of medicarpin on PTEN/AKT signal pathway in head and neck squamous cell carcinoma.
    Yiğin AK; Donmez H; Hitit M; Seven S; Eser N; Kurar E; Seven M
    J Cancer Res Ther; 2022; 18(1):180-184. PubMed ID: 35381781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
    Martin D; Abba MC; Molinolo AA; Vitale-Cross L; Wang Z; Zaida M; Delic NC; Samuels Y; Lyons JG; Gutkind JS
    Oncotarget; 2014 Oct; 5(19):8906-23. PubMed ID: 25275298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma.
    Yu GT; Mao L; Wu L; Deng WW; Bu LL; Liu JF; Chen L; Yang LL; Wu H; Zhang WF; Sun ZJ
    Cell Mol Life Sci; 2018 Nov; 75(22):4223-4234. PubMed ID: 29955905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.
    Mao L; Zhao ZL; Yu GT; Wu L; Deng WW; Li YC; Liu JF; Bu LL; Liu B; Kulkarni AB; Zhang WF; Zhang L; Sun ZJ
    Int J Cancer; 2018 Mar; 142(5):999-1009. PubMed ID: 29047105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.